Osteoarthritis (OA)
NICE guideline [NG226] Osteoarthritis in over 16s: diagnosis and management. Published Oct 2022.
NICE CKS Osteoarthritis. Last revised Dec 2023.
Background Information
Risk Factors
- Genetic contribution (independent of known environmental or demographic confounding factors)
- Biological factors
- Increasing age (typically >45 y/o)
- Women
- Overweight / obesity
- Low bone density
- Physical / biomechanical factors (causes of joint injury and damage)
- Joint laxity
- Reduced muscle strength
- Joint malalignment
- Exercise stresses
- Occupational stresses
Clinical Features
General Examination Findings
Possible findings include:
| Look |
|
| Feel |
|
| Move |
|
Findings in Knee OA
Typically bilateral and symmetrical.
Associated features:
- Giving way
- Locking
- Crepitus and tenderness along the joint line
- Restricted range of movement
Features seen in advanced disease:
- Bony swelling of the femoral condyles and lateral tibial plateau
- Varus deformity (more common than valgus)
- Antalgic gait
Medial tibiofemoral compartment knee OA is more common than lateral compartment OA.
Findings in Hip OA
- May present with deep pain in the anterior groin on walking or climbing stairs
- Painful restriction of internal rotation with the hip flexed
Features seen in advanced disease:
- Trendelenburg gait
- Fixed flexion external rotation deformity with compensatory lumbar lordosis and pelvic tilt
Findings in Hand OA
Typical joint involvement:
- 1st CMC joint
- PIP joint
- DIP joint
Other findings:
- Fixed flexion deformity of the CMC joint with hyperextension of the distal joints
- Squaring of the thumb
- Bouchard’s nodes (bony nodules next to the PIP joint)
- Heberden’s nodes (bony nodules next to the DIP joint)
In contrast to osteoarthritis, rheumatoid arthritis typically spares the DIP joints in the hands (+ feet).
X-ray in OA
Do NOT routinely use imaging to diagnose OA unless there are atypical features or features that suggest an alternative or additional diagnosis.
Typical radiological features of OA: (LOSS)
- Loss of joint space (or narrowing)
- Osteophyte formation
- Subchondral sclerosis
- Subchondral cysts
Note: structural changes on X-ray may not correlate with the presence or severity of symptoms or degree of functional impairment.
Complications
- Chronic pain
- Joint deformity
- Functional limitations
- Psychosocial impact
Guidelines
Investigation and Diagnosis
Clinical diagnosis of OA can be made if ALL of the following are present:
- ≥45 y/o, and
- Activity-related joint pain, and
- Morning joint stiffness lasting <30 min
Do not routinely use imaging to diagnose osteoarthritis unless there are atypical features or features that suggest an alternative or additional diagnosis.
Management
General Advice / Conservative Management
Offer:
- Weight management – if the patient is overweight / obese
- Advise that any amount of weight loss is beneficial but losing 10% is likely better than 5%
- Therapeutic exercise tailored to patients (e.g. local muscle strengthening, general aerobic fitness)
Consider:
- Manual therapy in hip / knee OA alongside therapeutic exercise
- Walking aids if there is lower limb OA
Do not routinely offer an aid or device (insoles / braces / tape / splints / supports), unless there is:
- Joint instability or abnormal biomechanical loading AND
- Therapeutic exercise is ineffective or unsuitable without it AND
- The addition of it is likely to improve movement and function
NICE recommends NOT to offer:
- Acupuncture
- Dry needling
- Electrotherapy (including transcutaneous electrical nerve stimulation, ultrasound therapy, interferential therapy, laser therapy, pulsed short-wave therapy, neuromuscular electrical stimulation)
Pharmacological Management
Pharmacological management should always be used alongside non-pharmacological options and at the lowest effective dose for the shortest possible time:
- 1st line: topical NSAID (useful for knee OA, but maybe less effective for other OAs)
- 2nd line: oral NSAID with gastroprotection
- 3rd line: paracetamol or weak opioid for short-term pain relief and infrequent use only
- 4th line: intra-articular corticosteroid injections (explain that it only provides 2-10 weeks of pain relief)
NICE recommends NOT to offer:
- Glucosamine (explain there is no strong evidence of benefit)
- Strong opioids (explain that the risks outweigh the benefits)
- Intra-articular hyaluronan injections
Surgical Management – Joint Replacement
Consider referring patients with knee / hip / shoulder OA for shoulder replacement if:
- Symptoms are substantially impacting quality of life, AND
- Non-surgical management is ineffective / unsuitable
Do not exclude people with OA from referral for joint replacement because of:
- Age
- Sex or gender
- Smoking
- Comorbidities
- Overweight or obesity, based on measurements such as BMI
NICE recommends NOT to offer arthroscopic lavage or debridement for OA.
References